Y Zevalin, BEAM and rituximab in autologous stem cell transplantation for lymphoma.
Phase of Trial: Phase I/II
Latest Information Update: 08 Jun 2015
At a glance
- Drugs Ibritumomab tiuxetan (Primary) ; Carmustine; Cytarabine; Etoposide; Filgrastim; Melphalan; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 23 Feb 2012 Company (Biogen Idec) added as trial sponsor as reported by ClinicalTrials.gov.
- 23 Feb 2012 Primary outcome amended as reported by ClinicalTrials.gov.
- 23 Feb 2012 Actual end date Nov 2011 added as reported by ClinicalTrials.gov.